Popular supplement's benefits 'greatly exaggerated,' evidence weak

A widely popular dietary supplement, often referred to as ciberžolė, is facing scrutiny over claims of its health benefits, particularly its purported anti-cancer and anti-inflammatory properties. Journalist Alice Klein reports that the scientific evidence backing these significant health claims is surprisingly weak. Despite its common use and praise, the foundation for its therapeutic effects appears to be less robust than widely believed.

“

Ciberžolė is often praised for its anti-cancer and anti-inflammatory properties, but the evidence supporting this is quite weak.

Klein's investigation highlights that while turmeric, the likely source of the supplement's active compound curcumin, is lauded for its potential health advantages, the specific data supporting its efficacy in supplement form is limited. Furthermore, the article raises concerns about the safety of consuming high concentrations of curcumin. The use of potent curcumin extracts in dietary supplements could carry inherent risks, suggesting that consumers should exercise caution and be aware of potential adverse effects beyond the often-overstated benefits.

“

Furthermore, consuming high doses of curcumin extract in the form of dietary supplements can be risky.